[Clinical and pathophysiologic effects of piretanide in nephrotic syndrome].
Plum
J
J
Abteilung für Nephrologie, Heinrich-Heine-Universität Düsseldorf.
Plum
F
F
Pooth
R
R
Grabensee
B
B
D000328:Adult; D009320:Atrial Natriuretic Factor / Q000097:blood*; D001810:Blood Volume / Q000187:drug effects / Q000502:physiology; D002395:Catecholamines / Q000097:blood*; D004232:Diuretics / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D012084:Renin-Angiotensin System / Q000187:drug effects* / Q000502:physiology; D013449:Sulfonamides / Q000627:therapeutic use*; D014882:Water-Electrolyte Balance / Q000187:drug effects / Q000502:physiology
D002395:Catecholamines; D004232:Diuretics; D013449:Sulfonamides; D009320:Atrial Natriuretic Factor; C015451:piretanide
Klinische und pathophysiologische Effekte der Piretanidbehandlung beim nephrotischen Syndrom.